BCBS of Mass. not covering Alzheimer's drug

By ABC 6 Boston
| October 08, 2021

BOSTON, Mass. (WLNE) – Blue Cross Blue Shield of Massachusetts will not be covering Aduhelm, a controversial new Alzheimer's drug. Blue Cross says while the drug shows promise, studies do not demonstrate that the benefits outweigh the risks.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...